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SHORT COMMUNICATION
Optimization of cutaneous electrically mediated
plasmid DNA delivery using novel electrode
LC Heller1,4, MJ Jaroszeski1,2, D Coppola3, AN McCray4, J Hickey2 and R Heller1,4
1Center for Molecular Delivery, University of South Florida, Tampa, FL, USA; 2Department of Chemical Engineering, University of
South Florida, Tampa, FL, USA; 3Department of Pathology, University of South Florida, Tampa, FL, USA and 4Department of Medical
Microbiology and Immunology, University of South Florida, Tampa, FL, USA
The easy accessibility of skin makes it an excellent target
for gene transfer protocols. To take advantage of skin as
a target for gene transfer, it is important to establish an
efficient and reproducible delivery system. Electroporation
is an established technique for enhancing plasmid
delivery to many tissues in vivo. A critical component of this
technique is the electrode configuration. Electroporation
parameters were optimized for transgene expression with
minimal tissue damage with a novel electrode. The highest
transgene expression and efficiency of individual cell
transformation with minimal damage was produced with
eight 150 ms pulses at field strength of 100 V/cm. This
electrode design offers the potential for easier and more
reproducible electrically mediated cutaneous plasmid deliv-
ery than the simple electrodes currently commercially
available. This electrode can be a valuable tool in determin-
ing the applicability of electrically mediated cutaneous gene
transfer.
Gene Therapy (2007) 14, 275–280. doi:10.1038/sj.gt.3302867;
published online 21 September 2006
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Introduction
Skin is an advantageous tissue for gene therapy,
primarily due to its accessibility. Expressed proteins
can be detected locally or systemically. Cutaneous
plasmid DNA delivery aided by in vivo electroporation
was first attempted in a newborn mouse model.1
Exponential pulses were delivered using a clip electrode
and analysis of transgene expression was performed
ex vivo. Since that time, several studies exploring plasmid
delivery using skin electroporation, primarily with
square wave pulses, have been published.
For electroporation gene delivery to skin, plasmid
DNA may be injected intradermally1–10 or biolistically.11
Pulses are applied to the skin surface or through
penetrating (needle) electrodes. Some electrode config-
urations are commercially available, although investiga-
tors often specifically design electrodes for in vivo
delivery. Caliper, plate, tweezer or clip type electrodes
grip a fold of skin.1,4–6,9,10 The meander7,11 and the N1/
N2 electrode8 are simply pressed against the injected
region. The applied pressure may vary. Invasive electro-
des used in cutaneous gene delivery include 2-needle,5
6-needle,12 and 7-pin arrays.2,3
Comparisons show that penetrating electrodes induce
higher levels of transgene expression,2,3,5 but these
electrodes raise the specter of needle insertion. Previous
studies have also shown that delivery is more efficient
when the field is applied in more than one direction.12–14
This approach permeabilizes more areas of the cell
membrane as well as more cells, which results in
increased expression and better distribution.14 When
nonpenetrating electrodes are used, better delivery is
obtained by rotating the plates 901 between sets of
pulses.13 To accomplish this, the electrodes are lifted off
the skin, repositioned, and a second set of pulses is
delivered. This delays the time between injection and
pulsing and also demands precise repositioning of the
electrodes with respect to the injection site. To alleviate
these problems, a new electrode designated four-plate
electrode (4PE, Figure 1) was developed.15 This electrode
contains four plates that grip a fold of skin and are
arranged to allow pulses in two electric field orientations
at a 901 angle to be administered without removing the
electrode from the skin. A nonconductive ‘stopper’ is
placed in the center to establish this constant distance.
The space between the electrodes, and therefore the
voltage setting, is consistent.
The purpose of these experiments was to explore
localized cutaneous plasmid delivery with the 4PE
electrode and to develop electroporation parameters that
would result in high expression levels. Two basic classes
of square wave electroporation parameters differing in
pulse length and amplitude were tested. Both localized
transgene expression and histological damage were
compared after the electrically mediated delivery of
plasmid DNA.
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Results and discussion
Comparison of 2-plate versus 4-plate electrode
designs
The 4PE was designed with a 6 mm distance between
parallel plates to fit around a 50 ml intradermal injection,
which results in a 6 mm bubble on the surface of the skin.
To determine if the 4PE could be used for skin transgene
delivery, expression of a plasmid encoding luciferase
delivered with the 4PE was compared to the commonly
used and commercially available caliper electrode type.
After injection of 100 mg pCMVLuc+ in 50 ml saline, eight
2 ms pulses at field strength of 800 V/cm were applied.
To duplicate delivery with the 4PE electrode, the caliper
electrode was placed in two perpendicular positions
with four pulses applied in each position. Luciferase
activity was determined as described in Figure 2.
Injection of plasmid without electroporation resulted in
production of 59727 total pg luciferase (n¼ 16). Delivery
with the caliper electrode significantly (Po0.05) in-
creased transgene expression to 15447555 total pg
(n¼ 16), while delivery with the 4PE significantly
increased expression to 218671079 total pg (n¼ 16).
The difference in transgene expression between the two
electrodes was not statistically significant.
It is important to note that although the 4PE electrode
covers a smaller surface area (0.8 cm2) than the caliper
electrode (2 cm2), the same level of transgene expression
was observed after delivery. Moreover, pulse application
was smoother and easier with the 4PE. The electrode
remains in contact with the tissue area injected through-
out pulsing. The timing between each set of pulses is
consistent and because the electrode spacing is preset,
the applied voltage is also consistent from one applica-
tion to the next.
Optimization of electroporation parameters with 4PE
Using the 4PE electrode, pulsing parameters were
optimized for the largest level of transgene expression
while minimizing tissue damage. Two different simplex
optimizations16 were tested to accommodate the two
classes of square waves used for in vivo electroporation.
Simplex A focused on low electric fields (25–800 V/cm)
and long pulses (1–200 ms), while simplex B focused on
higher electric fields (700–2000 V/cm) and short pulses
(10–1000 ms). Each simplex optimized on electric field
strength and pulse duration. Multiple iterations of the
simplex were run and more than 70 different pulsing
conditions were evaluated to determine the optimal
conditions. Some electroporation conditions were used
repeatedly for this optimization. The electroporation
Figure 1 4PE: (a) open position; (b) closed position. A 6 mm gap is
maintained between plates.
Figure 2 Comparison of luciferase expression after plasmid
delivery with two types of pulsing conditions. The flank skin of
6–7 weeks old female C57/Bl6 mice (NCI) was shaved and then
injected intradermally with 50 ml of 2 mg/ml pCMVLuc+ (a gift of
Claude Nicolau, Harvard Medical School, Boston, MA, USA), which
was prepared using Endo-free Megaprep kits (Qiagen, Valencia,
CA, USA). Eight electric pulses were administered with a 901
rotation between sets of four pulses at a frequency of 1 Hz with a
BTX T830 (BTX Molecular Delivery Systems, Holliston, MA, USA)
using the 4PE electrode. Mice were anesthetized in an induction
chamber charged with 3% isoflurane in O2 then fitted with a
standard rodent mask and kept under general anesthesia during
treatment. At 48 h after plasmid delivery, animals were humanely
euthanized, and the tissue samples were excised and analyzed. For
luciferase quantification, the tissue samples were homogenized in
buffer (50 mM K3PO4, 1 mM EDTA, 1 mM DTT, 10% glycerol) using a
Tissumizer (Tekmar, Cincinnati, OH, USA). Extracts were assayed
for luciferase activity32 and quantified using an MLX microtiter
plate luminometer (Dynex Technologies, Chantilly, VA, USA).
Activity is expressed in total pg luciferase per tissue sample. Values
represent mean and standard error. Due to the simplex scheme,
some pulsing conditions were repeated multiple times as indicated.
*Po0.05.
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pulsing conditions from both optimization schemes
resulting in the highest transgene expression were then
compared (Figure 2). Most of the conditions tested
yielded expression levels that were higher than injection
alone. Using the 4PE, short, high-voltage pulses in-
creased gene expression to as high as four-fold over
injection alone, while long, low-voltage pulses increased
in expression as high as 36-fold over injection alone.
Reporter expression peaked in a small range of pulse
field strengths (100–200 V/cm), while increasing pulse
length up to 200 ms increased transgene expression
(Figure 2). These data agree with expression optimiza-
tion studies performed in other tissues.17–20 A model
based on previously collected data21 analyzes viability
(V) as well as number of molecules taken up (N) after
electroporation delivery. For multiple pulses, the model
predicts that at field strengths of o1000 V/cm, the NV
increases as pulse length increases. The data shown here
tends to indicate a general increase in expression as pulse
length increases, which is in agreement with this model.
It is also interesting to note that expression levels could
be manipulated by careful selection of pulsing para-
meters.
Electroporation parameters can also be applied in two
distinct steps to include an electroporation pulse to
permeabilize the membrane followed by an electro-
phoretic pulse to move the plasmid through the
membrane.22–25 Previous studies have evaluated this
approach for in vivo plasmid DNA delivery to muscle.26–
27 In skin delivery, the electroporative–electrophoretic
pulse combination significantly increased gene expres-
sion levels (Po0.05) when compared to each component
pulse (Figure 3). However, these expression levels can be
obtained using a single pulse type (Figure 2). Therefore,
plasmid delivery can be performed either by combining
these two steps into a single pulse or administering two
distinct pulses. While early studies have presented a
strong case for the necessity of the electrophoretic
component,26–28 a recent study has presented evidence
to the contrary.29 The results presented in this study
question the necessity of the electrophoretic pulse for
electroporation gene transfer as significant increase in
expression was obtained with short (ms) pulses.
Although the mechanism of pulse combination may not
be fully understood, the advantage of applying the
pulses in two steps is that the amplitude of the electric
pulses can be reduced.
Luciferase expression levels do not predict whether a
small number of cells have been transfected with a large
plasmid copy number or the reverse. In order to
determine delivery efficiency, a plasmid encoding GFP
was delivered to the skin using four pulsing conditions
that generated high luciferase expression (Table 1). Cells
(20–30%) were positive after delivery with pulses
ranging from 100 to 200 V/cm at 20–150 ms. Therefore,
although high luciferase expression was seen using eight
150 ms pulses at 100 V/cm, the total number of cells
expressing the transgene was not significantly increased.
These conditions may result in a larger plasmid copy
number entering each electroporated cell or in better
nuclear delivery. Finally, with field strength of 400 V/cm,
the positive cell number decreased significantly.
For future clinical considerations, it is important to
document any tissue damage that may be caused by the
application of electric pulses. Tissue health following
electric pulse application is an important criterion to
evaluate delivery. The four electroporation conditions
used in Table 1 were used to assess histological damage
following removal of the 6 mm diameter treated area of
skin. Multiple sections of each sample were examined
following hematoxylin and eosin staining. Samples were
graded for percent damage using a schema including
surface damage (burning and or necrosis), inflammation
and subepidermal necrosis.30 The total amount of
damage (surface and subepidermal area affected) was
determined for each sample and expressed as a
percentage of the total treatment area. Although minimal
Figure 3 Combination of electroporation and electrophoresis. One
hundred micrograms of pCMVLuc+ were delivered and luciferase
assays were performed as described in Figure 2. Bars represent the
mean of the means and standard error of the means for two
replicate experiments. Each experiment contained four samples for
each group. *Po0.05 with respect to G+E-; **Po0.05 with respect to
electroporation pulse; ***Po0.05 with respect to electrophoretic
pulse.
Table 1 Transfected cell distribution in skin samples after plasmid
delivery with electroporation conditions resulting in high and
consistent luciferase expression
Pulsing conditions Total pg per tissue % GFP positive cells
Injection only 93717 0
100 V/cm 20 ms 14857496 19.75712.74
100 V/cm 150 ms 25587581 32.0674.55
200 V/cm 20 ms 13797526 32.25711.16
400 V/cm 10 ms 10577194 8.574.57
pEGFP-N1 (Clontech, Palo Alto, CA, USA), encoding green
fluorescent protein (GFP), was prepared using Endo-free Qiagen
Megaprep kits (Qiagen, Valencia, CA, USA) and was injected
intradermally followed by electroporation at the specified para-
meters (mice were anesthetized and treatment performed as
described in Figure 2). At 48 hours after procedure, the entire
treated area was removed and evaluated for GFP expression. Each
tissue sample was evaluated (entire 6 mm diameter area, unsec-
tioned) using a fluorescent microscope and the percentage of each
sample that was fluorescent was determined visually. Results
represent the mean and s.d. for two replicate experiments with n
of 4 for each experiment.
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levels of damage were observed under any pulsing
conditions, the primary effect observed was surface
burns or scars and the appearance of localized sub-
epidermal necrosis (Figure 4). Low damage levels were
observed with pulses ranging from 100 to 200 V/cm at
20–150 ms (Table 2). In this limited study, field strength
appeared to be the most important variable in determin-
ing levels of cutaneous damage, since even relatively
short pulses (10 ms) at the highest field strength (400 V/
cm) tested resulted in detectable tissue damage. This
does not agree with a previous study exploring the effect
of pulse delivery on skin integrity in hairless rats.31 In
that study, no significant inflammation or necrosis was
observed histologically after electroporation with 10
pulses at a similar field strength (558 V/cm) and pulse
length (5 ms). This may be due to the specific definition
of damage, the difference in skin thickness in the animals
compared or to the electrode used in the delivery.
Kinetics of expression and dose response
Since 150 ms pulses at field strength of 100 V/cm
resulted in the highest and most consistent transgene
expression with minimal tissue damage, these pulses
were tested in additional experiments. Transgene ex-
pression levels were increased over injection alone up to
2 weeks after electrically mediated delivery. A significant
Figure 4 Tissue damage following electroporation. Photographs of representative sections from study described in Table 2 illustrate
examples of surface damage and subepidermal necrosis. (a and c) An area with surface damage is shown. (a)  100 magnification and (c)
 400 magnification. (b and d) An area containing subepidermal necrosis is shown. (b)  100 magnification and (d)  400 magnification.
Arrows point to the areas of normal tissue and stars are placed in the areas of damage.
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increase in mean expression was observed at 48 h
(18597696 total pg luciferase), 7 days (16277757) and
14 days (15157700) when compared to injection alone
(110723, 123742 and 4097179 total pg luciferase
respectively, n¼ 12). Expression levels decreased at day
17. Interestingly, after subcutaneous injection alone,
luciferase expression levels tended to increase slowly
over the time period tested. By day 17, expression in
samples that received plasmid injection alone (7967401
total pg) was not significantly different from expression
levels with electroporation (6457234 total pg). If a subtle
onset of expression is desirable, for example, in a specific
therapeutic situation, simple injection may be the
optimal form of plasmid delivery.
In a plasmid dose response, electroporation increased
expression significantly at doses greater than 50 mg
(Figure 5). Luciferase expression increased linearly up
to 200 mg plasmid injected, indicating that maximum
expression levels were not reached.
Summary
The results presented here demonstrate that in vivo
electroporation enhances intradermal delivery of plas-
mid DNA. An important consideration for optimal
delivery is the configuration of the electrodes that are
used to apply the electric fields. This electrode design
offers the potential for easier and more rapid application
of electrically mediated cutaneous plasmid delivery than
the electrodes currently commercially available. Of the
electroporation parameters tested with this electrode,
150 ms pulses with field strength of 100 V/cm produced
the highest and most consistent transgene expression,
a high efficiency of individual cell transformation, and
minimal tissue damage. While these results are encoura-
ging, the next step for this system will be an evaluation
in an appropriate disease model and eventual translation
into clinical trials.
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